Stay updated on ACTT: Remdesivir for Severe COVID-19 Clinical Trial
Sign up to get notified when there's something new on the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page.

Latest updates to the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page
- Check2 days agoChange DetectedThe page now shows 'No longer looking for participants' to signal enrollment is closed, and it adds guidance sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', while updating the revision stamp to v3.6.0 and adjusting the Intervention/Treatment heading.SummaryDifference0.3%

- Check9 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing the previous Revision: v3.5.4. This indicates an updated version of the associated document on the page.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedA new revision tag v3.5.4 was added and the previous tag v3.5.3 was removed, indicating an update to the page's revision history rather than substantive changes to the study details.SummaryDifference0.0%

- Check52 days agoChange DetectedThe page now shows an updated ClinicalTrials.gov interface revision (from v3.5.2 to v3.5.3). This reflects a minor platform/version update rather than a change to the study record content.SummaryDifference0.0%

- Check59 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check88 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to ACTT: Remdesivir for Severe COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page.